Dietary Supplements

Daily multivitamin may improve cognition, may protect against decline: RCT

14-Sep-2022 By Stephen Daniells

Multivitamin supplements may improve cognition, episodic memory, and executive function in older people, and slow cognitive decline by 60%, according to data from the high-profile COcoa Supplement and Multivitamin Outcomes Study for the Mind (COSMOS-Mind).

Personalized nutrition player Lykon raises €10 million

12-Sep-2022 By Stephen Daniells

The Series A financing round will enable the Berlin-based personalized nutrition player to develop new markets and target groups, says Lykon’s CEO.

Multivitamin-ginseng formula relieves stress markers in controlled trial

31-Aug-2022 By Hank Schultz

A supplement formula consisting of vitamins, minerals and ginseng was found to lessen psychological symptoms and blood markers of stress in a controlled trial, the manufacturer claims.

‘A wake-up call to American healthcare policy makers’: Report highlights billions in potential savings from supplements

31-Aug-2022 By Stephen Daniells

Dietary supplement regimens may reduce the direct and indirect medical costs associated with specific disease-associated medical conditions, but only $59 billion are currently being captured, potentially leaving $502 billion in additional savings that...

Solara Labs rides fast melt tech and ecommerce success to spot on Inc 5000 list

30-Aug-2022 By Hank Schultz

Florida-based supplement manufacturer Solara Labs has again made the Inc. 5000 list of fastest growing privately-held companies.

Mannatech’s brief momentum surge seems over with steep sales decline

30-Aug-2022 By Hank Schultz

Multilevel marketing company Mannatech saw sales fall by more than 17% in its latest earnings report.

NAC supplements back on Amazon

25-Aug-2022 By Stephen Daniells

After a hiatus of over a year, Amazon is again selling NAC-containing dietary supplement products. The development was described as exciting by one industry trade association.

AHPA’s updated Hemp Lexicon seeks to shed light on ‘full spectrum’ question

25-Aug-2022 By Hank Schultz

The American Herbal Products Association has released a new guidance document that seeks to bring clarity to hemp nomenclature, in particular what ought to be meant by the terms ‘broad spectrum’ and ‘full spectrum’ extracts.

Warning letter alleges company used raw materials tainted with glass and plastic

24-Aug-2022 By Hank Schultz

An FDA warning letter sent to supplement manufacturer Oregon’s Wild Harvest said the company failed to demonstrate that it had a valid method for assuring that incoming raw material lots were free of contaminants.

Supplement firm sees opportunity in stress epidemic

23-Aug-2022 By Hank Schultz

A supplement firm capitalizing on the ‘biohacking’ trend has released a new supplement it says addresses the epidemic of stress that followed in the wake of the pandemic.

Vetting suppliers becomes ever more crucial as US-China tensions rise

18-Aug-2022 By Hank Schultz

Heightened US-China tensions have caused planners in all industrial sectors to reevaluate their sourcing arrangements. Stakeholders in the dietary supplement industry say having firm relationships with well-vetted suppliers is the best way to manage...

Youtheory announces first new product launch following its acquisition by Jamieson

16-Aug-2022 By Hank Schultz

Youtheory, a supplement brand that made its name popularizing collagen, is expanding its reach with the launch of a new line of liquid dietary supplements.

Metagenics strengthens EU presence with Nutri Advanced acquisition

16-Aug-2022 By Nicola Gordon-Seymour

UK supplements retailer, Nutri Advanced, has been acquired by Metagenics for an undisclosed sum.

CRN: Progress being made on MPL provisions in fees bill

04-Aug-2022 By Hank Schultz

Significant progress is being made on a mandatory product listing requirement that the industry can live with, CRN asserts.

Congress explores how Farm Bill could hasten CBD regulations, market development

02-Aug-2022 By Elizabeth Crawford

On Capitol Hill last week, hemp industry stakeholders and Congressional leaders frustrated by FDA’s lack of regulations for CBD and other hemp-derived compounds since the 2018 Farm Bill authorized commercial production of the crop, explored how the 2023...

DeLauro/Durbin move to split up FDA has earlier precedents, expert says

28-Jul-2022 By Hank Schultz

Splitting the food safety responsibilities off from the US Food and Drug Administration is not a new idea, said a prominent industry consultant.

Study finds supplements with dodgy ingredients still for sale years after warning letters

26-Jul-2022 By Hank Schultz

A new study from a team headed by prominent industry critic Dr Pieter Cohen, MD, found that FDA warning letters did not prevent the subsequent sale of supplements with dodgy ingredients.

CRN: Few firms will file NDIs under current guidance

21-Jul-2022 By Hank Schultz

The Council for Responsible Nutrition said that persistent problems with FDA’s NDI Draft Guidance means that few firms likely will file new notifications during the recently announced amnesty window.

Young Living warning letter points to need among MLMs to have plan to police language used by distributors

20-Jul-2022 By Hank Schultz

A warning letter sent to Young Living, a multi level marketing company specializing in essential oils, underscores the importance of having a social media monitoring program in place to avoid running afoul of regulators.

New ISSN position paper gives nutritional guidance for warfighters, first responders

19-Jul-2022 By Hank Schultz

A new sports nutrition position paper outlines nutritional recommendations for warfighters while stressing how much more research needs to be done to pin down precise deficits and requirements for troops engaged in ongoing operations.

FDA cites four more honey products for knockoff ED drugs

18-Jul-2022 By Hank Schultz

The US Food and Drug Administration has sent warning letters to four companies marketing sexual enhancement supplements ostensibly based on honey but which contained undeclared ED drugs. The warning letters were part of a ongoing enforcement effort on...

Sen Burr strips out supplement provisions from new FDA user fee bill

15-Jul-2022 By Stephen Daniells

Senator Richard Burr (R-NC), the ranking member of the Senate HELP Committee, has introduced a reauthorization of FDA User Fee Programs which does not include dietary supplement provisions.

FDA, FTC combine to tackle opiod claims in kratom warning letters

08-Jul-2022 By Hank Schultz

FDA and FTC have issued four joint warning letters to kratom companies centered on opioid claims. It’s a move that comes on the heels of FDA rejecting an NDI filing on the ingredient for the sixth time.

US ranked high in adoption of alternative therapies

06-Jul-2022 By Hank Schultz

American consumers ranked high in their use of alternative health strategies according a recently published analysis of population cohort studies

7 key takeaways from the CRN-ACI Legal, Regulatory & Compliance Summit

05-Jul-2022 By Stephen Daniells

NDIs, drug preclusions, the CBD stalemate, actions at the State level, and an impending supply chain nightmare around plastics were just some of the highlights from a recent conference in New York City.

AHPA urges stakeholders to oppose MPL provisions in FDA fees bill

30-Jun-2022 By Hank Schultz

The American Herbal Products Association is urging members and stakeholders to contact lawmakers to oppose the mandatory product listing language that has been attached to a ‘must pass’ fee reauthorization bill.

Majority of CBD products tested in study found to have at least some THC

29-Jun-2022 By Hank Schultz

A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.

Dr Rob Wildman on NDI submissions, implementing MPL

28-Jun-2022 By Danielle Masterson

This year’s International Society of Sports Nutrition Annual Conference & Expo marked its 19th year promoting the science and application of evidence-based sports nutrition and supplementation. NutraIngredients-USA was there to hear about the latest...

NOW reveals new trick spotted on Amazon to deceive consumers about product quality

28-Jun-2022 By Hank Schultz

In an ongoing market surveillance program, supplement manufacturer NOW has revealed a new trick spotted on Amazon to deceive consumers about what a product’s testing results actually mean.

Part 2

FDA’s Welch on enforcement: ‘Sometimes you need a hammer but, at times, the hammer is not the best option’

28-Jun-2022 By Stephen Daniells

Ingredient-specific actions, as evidenced recently by warning letters to 10 firms in the sports nutrition space, are important to FDA’s regulation of dietary supplements but additional actions are hampered by having to deal with problematic ingredients...

Onnit Labs evaluates New Mood effects on college student stress

24-Jun-2022 By Asia Sherman

Health and wellness company Onnit has added a new study to its growing portfolio of clinical trials to validate the benefits of the “total human optimization” brand’s range of multi-ingredient supplements.

California weight management supplement bill advances past committee

23-Jun-2022 By Stephen Daniells

A California bill that seeks to place restrictions on the sale of some weight management supplements to minors has passed the State’s Judiciary Committee, and now moves forward to the Senate Appropriations Committee.

USPSTF’s multivitamin report: ‘Akin to studying a hammer and concluding it is unsuitable for turning a screw’

23-Jun-2022 By Stephen Daniells

The dietary supplements industry has reacted to a recent report from the U.S. Preventive Services Task Force that dismissed the potential benefits of multivitamins for the prevention of cardiovascular disease and cancer.

FDA revisits safety of CBD for use in dietary supplements, industry not satisfied

23-Jun-2022 By Asia Sherman

Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.

CHPA adds Larisa Pavlick as new Sr Director of QA and Technical Affairs

22-Jun-2022 By Stephen Daniells

Pavlick joins the Consumer Healthcare Products Association’s regulatory and scientific affairs team after almost six years at the United Natural Product Alliance (UNPA).

AHPA withdraws objections to California weight loss bill

17-Jun-2022 By Stephen Daniells

Recent amendments to a California bill that seeks to place restrictions on the sale of some weight management supplements to minors removed retail access restrictions and clarifies definitions, leading one trade association to remove its objections.

Industry stakeholders spar over whether pushing for MPL has been tactical error

16-Jun-2022 By Hank Schultz

Mandatory Product Listing can still be a good idea for industry, proponents maintain, even if the latest legislative iteration has failed to garner support from stakeholders.

Trade organizations line up against bill that includes new supplement regulations

15-Jun-2022 By Hank Schultz

Three trade organizations joined forces in opposing the FDA Safety and Landmark Advancement Act of 2022 (FDASLA), a fee authorization bill that includes provisions aimed at tightening dietary supplement regulations.

Romney's amendments to Murray/Burr bill called ‘negotiating tactic’

14-Jun-2022 By Hank Schultz

Amendments offered by Sen. Mitt Romney, R-UT, could soften some of the hardest edges in an FDA fee reauthorization bill that includes language meant to tighten the regulation of dietary supplements. But the bill still sets a very troubling precedent,...

FDA working ‘expeditiously’ to finalize NDI draft guidance sections

13-Jun-2022 By Stephen Daniells

The US Food & Drug Administration intends to release multiple draft guidance documents to the industry as smaller, discreet topics relating to New Dietary Ingredients (NDI), a senior figure said recently.

New supplement rules tacked on to bill authorizing FDA fees

10-Jun-2022 By Hank Schultz

Authors of a bipartisan bill to reauthorize FDA user fees have included provisions bearing on dietary supplements, which has stirred up a hornets nest within the industry.

FDA releases consumer resource for supplements

06-Jun-2022 By Hank Schultz

The US Food and Drug Administration has released a consumer-aimed education resource for dietary supplements.

Review calls for reassessment of upper levels for zinc intake in preadolescent children

25-May-2022 By Asia Sherman

Research published in Nutrients suggests that existing upper levels of zinc among infants and young children should be updated with a newer body of relevant evidence.

Alkemist Labs launches quality program featuring easy to read test results, verification seal for labels

24-May-2022 By Hank Schultz

Alkemist Labs has announced a new quality and transparency program featuring validated, simplified test documents that can be shared with clients and customers. It’s the culmination of a seven year development process, the company said.

Study unlocks Choline’s ‘unique role’ in boosting DHA levels during pregnancy

19-May-2022 By Stephen Daniells

Maternal intake of choline, an essential brain nutrient for mother and developing child, significantly increases DHA status, more than supplementing with DHA by itself, says a new study from Cornell University.

Walgreens becomes first to use UL Verified Mark on supplement labels

18-May-2022 By Hank Schultz

Global safety certifier UL has announced a new UL Verified Mark will debut on Walgreens brand vitamins and supplements. The new partnership was announced yesterday.

FDA reiterates that ‘FDA approved’ is a bogus phrase in most cases

11-May-2022 By Hank Schultz

The US Food and Drug Administration has issued a document reminding consumers that in only a few cases is ‘FDA approved’ a factual statement.

FDA cites 10 firms for use of ingredients flagged as illegal

10-May-2022 By Hank Schultz

In a coordinated enforcement action, FDA has sent warning letters to 10 dietary supplement companies using ingredients that have been added to its Ingredients Advisory List.

NOW marks next phase of growth with new ad campaign

09-May-2022 By Danielle Masterson

Founder Elwood Richard’s motto was that good health should be affordable–a message that laid the groundwork for the campaign.

Nature’s Sunshine joins Usana among firms relying on sales in Asia

06-May-2022 By Hank Schultz

Multilevel marketing organization Nature’s Sunshine managed to post a significant revenue increase in its first quarter earnings statement, despite supply chain challenges that caused out of stock situations and an overall net loss.